Interestingly, Erickson, et al. have recently shown that AKT degradation but not kinase inhibition modulates expressions of genes critical for cholesterol metabolism in breast cancer cells, which is highly supportive of our results in pancreatic cancer cells [12]. The gene discussed is AKT1; the disease is breast cancer.